A
Alok Srivastava
Researcher at Christian Medical College & Hospital
Publications - 356
Citations - 7156
Alok Srivastava is an academic researcher from Christian Medical College & Hospital. The author has contributed to research in topics: Transplantation & Medicine. The author has an hindex of 40, co-authored 305 publications receiving 5571 citations.
Papers
More filters
Journal ArticleDOI
WFH Guidelines for the Management of Hemophilia, 3rd edition
Alok Srivastava,Elena Santagostino,Alison Dougall,Steve Kitchen,Megan Sutherland,Steven W. Pipe,Manuel Carcao,Johnny Mahlangu,Margaret V. Ragni,Jerzy Windyga,Adolfo Llinás,Nicholas J. Goddard,Richa Mohan,Pradeep M. Poonnoose,Brian M. Feldman,Sandra Zelman Lewis,H. Marijke van den Berg,Glenn F. Pierce +17 more
TL;DR: The WFH Guidelines for the Management of Hemophilia panelists and co-authors thank the panelists for their time and share their views on how to better understand and treat hemophilia.
Journal ArticleDOI
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity.
Vikram Mathews,Biju George,Kavitha M Lakshmi,Auro Viswabandya,Ashish Bajel,Poonkuzhali Balasubramanian,Ramachandran V Shaji,Vivi M. Srivastava,Alok Srivastava,Mammen Chandy +9 more
TL;DR: Single-agent As2O3, as used in this series, in the management of newly diagnosed cases of APL, is associated with responses comparable with conventional chemotherapy regimens, and has minimal toxicity and can be administered on an outpatient basis after remission induction.
Journal ArticleDOI
Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data
Vikram Mathews,Biju George,Ezhilarasi Chendamarai,Kavitha M Lakshmi,Salamun Desire,Poonkuzhali Balasubramanian,Auro Viswabandya,Rajashekar Thirugnanam,Aby Abraham,Ramachandran V Shaji,Alok Srivastava,Mammen Chandy +11 more
TL;DR: Single-agent ATO as used in this study in the management of newly diagnosed cases of APL is safe and is associated with durable responses while results in the low-risk group are comparable to that reported with conventional therapy while additional interventions would probably be required in high-risk cases.
Journal ArticleDOI
New ISSCR Guidelines Underscore Major Principles for Responsible Translational Stem Cell Research
Insoo Hyun,Olle Lindvall,Lars Ährlund-Richter,Elena Cattaneo,Marina Cavazzana-Calvo,Giulio Cossu,Michele De Luca,Ira J. Fox,Claude Gerstle,Robert A. Goldstein,Göran Hermerén,Katherine A. High,Hyun Ok Kim,Hin-Peng Lee,Ephrat Levy-Lahad,Lingsong Li,Bernard Lo,Daniel Robert Marshak,Angela McNab,Megan Munsie,Hiromitsu Nakauchi,Mahendra S. Rao,Heather M. Rooke,Carlos Simon Valles,Alok Srivastava,Jeremy Sugarman,Patrick L. Taylor,Anna Veiga,Adrianne L. Wong,Laurie Zoloth,George Q. Daley +30 more
TL;DR: The International Society for Stem Cell Research (ISSCR) task force that developed new Guidelines for the Clinical Translation of Stem Cells discusses core principles that should guide the responsible transition of basic stem cell research into appropriate clinical applications as discussed by the authors.
New ISSCR Guidelines Underscore Major Principles for Responsible Translational Stem Cell Research. [5YIF: 24.57, Citations: 116]
Insoo Hyun,Olle Lindvall,L Ahrlund Richter,Elena Cattaneo,M Cavazzana Calvo,Giulio Cossu,Michele De Luca,Ij Fox,Claude Gerstle,Ra Goldstein,Göran Hermerén,Ka High,Ho Kim,Hp Lee,E Levy Lahad,Lianqing Li,Bernard Lo,Marshak,Angela McNab,Megan Munsie,Hiromitsu Nakauchi,Mahendra S. Rao,Hm Rooke,Cs Valles,Alok Srivastava,Jeremy Sugarman,Pl Taylor,Anna Veiga,Al Wong,Laurie Zoloth,George Q. Daley +30 more
TL;DR: The International Society for Stem Cell Research task force that developed new Guidelines for the Clinical Translation of Stem Cells discusses core principles that should guide the responsible transition of basic stem cell research into appropriate clinical applications.